GLI1 and cervical cancer: In view of active GLI signaling in cervical cancer cells, inhibition of GLI signaling was attempted by subjecting the cells to treatment of cyclopamine (10, 20, 40, 80 μM) for 24 h, a selective inhibitor that blocks GLI signaling by inhibition of Smo activity (Fig. 2a).